OBJECTIVE: Alcohol withdrawal syndrome poses a significant health burden worldwide, with its prevalence steadily rising in countries like India due to high rates of alcohol use disorders. The treatment landscape for alcohol withdrawal syndrome is evolving with the introduction of bromocriptine offering a promising adjunctive treatment for patients resistant to standard benzodiazepine therapy. METHODS: We report two cases from India of severe alcohol withdrawal syndrome successfully treated with bromocriptine. RESULTS: There were clinically significant improvements in both patients with regard to Alcohol Withdrawal Symptoms in a relatively short time span. CONCLUSIONS: Bromocriptine represents an addition to the therapeutic options for alcohol withdrawal syndrome management, offering symptom relief, improving clinical outcomes, and addressing the neuropsychiatric burden associated with the condition.